On 22 November 2017, the European Commission (the “Commission”) adopted new Guidelines on Good Manufacturing Practice (“GMP”) specific to Advanced Therapy Medicinal Products (“ATMPs”) (the “Guidelines”). The Guidelines provide for a specific GMP framework that is adapted to the characteristics of ATMPs. Read more...